Publikationstyp: Beitrag in wissenschaftlicher Zeitschrift
Art der Begutachtung: Peer review (Publikation)
Titel: The Scar‐in‐a‐Jar : studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well
Autor/-in: Chen, C.Z.C.
Fish, P.V.
Peng, Y.X.
Wang, Z.B.
Kaar, J.L.
Koepsel, R.R.
Russell, A.J .
Lareu, R.R.
Raghunath, M.
DOI: 10.1111/j.1476-5381.2009.00387.x
Erschienen in: British Journal of Pharmacology
Band(Heft): 158
Heft: 5
Seite(n): 1196
Seiten bis: 1209
Erscheinungsdatum: 2009
Verlag / Hrsg. Institution: The British Pharmacological Society
ISSN: 1476-5381
0007-1188
Sprache: Englisch
Fachgebiet (DDC): 572: Biochemie
Zusammenfassung: Background and purpose: Fibrosis, a pathological accumulation of collagen in tissues, represents a major global disease burden. Effective characterization of potential antifibrotic drugs has been constrained by poor formation of the extracellular matrix in vitro, due to tardy procollagen processing by collagen C‐proteinase/BMP‐1, and difficulties in relating this matrix to cell numbers in experimental samples. Experimental approach: The Scar‐in‐a‐Jar model provided, in vitro, the complete biosynthetic cascade of collagen matrix formation including complete conversion of procollagen by C‐proteinase/BMP‐1, its subsequent extracellular deposition and lysyl oxidase‐mediated cross‐linking, achieved by applying the biophysical principle of macromolecular ‘crowding’. Collagen matrix deposition, velocity and morphology can be controlled using negatively charged ‘crowders’ in a rapid (2 days) mode or a mixture of neutral ‘crowders’ in an accelerated (6 days) mode. Combined with quantitative optical bioimaging, this novel system allows for in situ assessment of the area of deposited collagen(s) per cell. Key results: Optical evaluation of known and novel antifibrotic compounds effective at the epigenetic, post‐transcriptional/translational/secretional level correlated excellently with corresponding biochemical analyses. Focusing on quantitation of deposited collagen, the Scar‐in‐a‐Jar was most effective in assessing novel inhibitors that may have multiple targets, such as microRNA29c, found to be a promising antifibrotic agent. Conclusions and implications: This novel screening system supersedes current in vitro fibroplasia models, as a fast, quantitative and non‐destructive technique. This method distinguishes a reduction in collagen I deposition, excluding collagen cross‐linking, and allows full evaluation of inhibitors of C‐proteinase/BMP‐1 and other matrix metalloproteinases.
URI: https://digitalcollection.zhaw.ch/handle/11475/12213
Volltext Version: Publizierte Version
Lizenz (gemäss Verlagsvertrag): Lizenz gemäss Verlagsvertrag
Departement: Life Sciences und Facility Management
Organisationseinheit: Institut für Chemie und Biotechnologie (ICBT)
Enthalten in den Sammlungen:Publikationen Life Sciences und Facility Management

Dateien zu dieser Ressource:
Es gibt keine Dateien zu dieser Ressource.
Zur Langanzeige
Chen, C. Z. C., Fish, P. V., Peng, Y. X., Wang, Z. B., Kaar, J. L., Koepsel, R. R., Russell, A. J., Lareu, R. R., & Raghunath, M. (2009). The Scar‐in‐a‐Jar : studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well. British Journal of Pharmacology, 158(5), 1196–1209. https://doi.org/10.1111/j.1476-5381.2009.00387.x
Chen, C.Z.C. et al. (2009) ‘The Scar‐in‐a‐Jar : studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well’, British Journal of Pharmacology, 158(5), pp. 1196–1209. Available at: https://doi.org/10.1111/j.1476-5381.2009.00387.x.
C. Z. C. Chen et al., “The Scar‐in‐a‐Jar : studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well,” British Journal of Pharmacology, vol. 158, no. 5, pp. 1196–1209, 2009, doi: 10.1111/j.1476-5381.2009.00387.x.
CHEN, C.Z.C., P.V. FISH, Y.X. PENG, Z.B. WANG, J.L. KAAR, R.R. KOEPSEL, A.J . RUSSELL, R.R. LAREU und M. RAGHUNATH, 2009. The Scar‐in‐a‐Jar : studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well. British Journal of Pharmacology. 2009. Bd. 158, Nr. 5, S. 1196–1209. DOI 10.1111/j.1476-5381.2009.00387.x
Chen, C.Z.C., P.V. Fish, Y.X. Peng, Z.B. Wang, J.L. Kaar, R.R. Koepsel, A.J . Russell, R.R. Lareu, and M. Raghunath. 2009. “The Scar‐in‐a‐Jar : Studying Potential Antifibrotic Compounds from the Epigenetic to Extracellular Level in a Single Well.” British Journal of Pharmacology 158 (5): 1196–1209. https://doi.org/10.1111/j.1476-5381.2009.00387.x.
Chen, C. Z. C., et al. “The Scar‐in‐a‐Jar : Studying Potential Antifibrotic Compounds from the Epigenetic to Extracellular Level in a Single Well.” British Journal of Pharmacology, vol. 158, no. 5, 2009, pp. 1196–209, https://doi.org/10.1111/j.1476-5381.2009.00387.x.


Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.